| Literature DB >> 32793599 |
Mohammad Khursheed Alam1, Ahmed Ali Alfawzan2.
Abstract
OBJECTIVES: To evaluate sella turcica (ST) bridging, associated anomalies, and morphology, in subjects with four different types of clefts, and compare them with non-cleft (NC) subjects.Entities:
Keywords: bilateral cleft lip and palate; morphometry; sella turcica; sella turcica bridging; unilateral cleft lip and palate
Year: 2020 PMID: 32793599 PMCID: PMC7387404 DOI: 10.3389/fcell.2020.00656
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X
Demographic details and methods.
| Population | Saudi subjects | ||||||
| Inclusion and exclusion criteria | Non syndromic cleft subjects with good quality x-ray images. No history of craniofacial surgical treatment besides lip and palate surgery. No orthodontic treatment has been done. No anatomical variation in the ST and sphenoidal regions. Matched with healthy control without any craniofacial deformity. Subjects using hormonal medications or corticosteroids were excluded from the study. | ||||||
| Sampling | Convenient sampling following inclusion and exclusion criteria. | ||||||
| Subjects distribution | Male | 14 | 19 | 26 | 3 | 7 | |
| Female | 17 | 10 | 15 | 6 | 6 | ||
| Total ( | 31 | 29 | 41 | 9 | 13 | ||
| Age | 13.29 ± 3.52 | 14.07 ± 4.73 | 14.32 ± 4.46 | 12.78 ± 4.09 | 13.31 ± 4.46 | ||
| Data used | Digital lateral cephalogram, orthopantomogram, and clinical record details. | ||||||
| Ethical clearance | Protocol has been presented to the ethical board of Alrass Dental Research Center, Qassim University. Ethical clearance has been obtained with the Code #: DRC/009FA/20. | ||||||
| Landmarks used and the details | TS | Tuberculum sella | The most anterior point of the contour of the sella turcica | ||||
| DS | Dorsum sellae | The posterior wall of the sella turcica | |||||
| SF | Sella floor | The deepest point on the floor of pituitary fossa | |||||
| Pclin | Posterior clenoid | The most anterior point of the PClin process | |||||
| SA | Sella anterior | The most anterior point of the sella | |||||
| SP | Sella posterior | The most posterior point of the sella | |||||
| SM | Sella median | A point midway between PClin and TS | |||||
| a | Sella length | TS-Pclin | Changes in the size of sella turcica are often identified with the pathology of pituitary gland and may have an undetected hidden disease; hence, sella length is one of the parameters to determine the sella size. | ||||
| b | Sella width | SA-SP | Utilized clinically for pubertal growth phase determination, would be increased by advanced age, it has strong correlation with age. | ||||
| c | Sella diameter | TS-DS | Growth of an individual can be assessed based on the diameter of the sella turcica at different age periods. | ||||
| d | Sella height anterior | TS-SF | As the anterior part of the sella turcica is believed to develop mainly from neural crest cell, so we need to measure the sella height anterior. So that, we can assume or determine any structural deviation in the anterior wall which are believed to be associated with the specific deviation in the facial structure. | ||||
| e | Sella height posterior | PClin-SF | The posterior part of the sella turcica develops from the para-axial-mesoderm, which develops approximately 7 weeks of gestation. If any disturbance occurs in this area it remains throughout the life, as the time of formation of sella closely associated with the development of maxilla. So that, it may be assumed that any aberration leading to cleft may be associated with some fault at the level of sella turcica. | ||||
| f | Sella height median | SM-SF | Utilized clinically for pubertal growth phase determination, would be increased with age. | ||||
| g | Sella area | TS-SA-SF-SP-Pclin | During embryological development of the sella area is the key point for the migration of the neural crest cells to the fronto nasal and maxillary developmental fields. Pituitary fossa increased in size with age and found a positive correlation of the area of the sella to age. | ||||
FIGURE 1Lateral cephalogram view of sella turcica in (A) BCLP, (B) UCLP, (C) sella turcica parameters: (a) TS-Pclin; (b) SA-SP; (c) TS-DS; (d) TS-SF; (e) PClin-SF; (f) SM-SF; and (g) sella area, (D) Control, and (E) UCLA subjects.
Sella turcica bridging, type of malocclusion and associated anomalies.
| Gender | Sella bridging | Subject | Skeletal malocclusion | Dental anomalies | Prevalence |
| F | Complete | Non-cleft | Class I | IC | Non-cleft = 6.45% |
| M | Partial | Non-cleft | Class II | IC | |
| F | Partial | Bilateral Cleft Lip and Palate | Class III | CM + IC | BCLP = 20.69% |
| M | Partial | Bilateral Cleft Lip and Palate | Class III | CM | |
| M | Partial | Bilateral Cleft Lip and Palate | Class III | None | |
| M | Partial | Bilateral Cleft Lip and Palate | Class III | CM | |
| M | Partial | Bilateral Cleft Lip and Palate | Class III | CM + IC | |
| M | Partial | Bilateral Cleft Lip and Palate | Class III | None | |
| M | Partial | Unilateral Cleft Lip and Palate Lt Side | Class III | CM | UCLP = 24.39% |
| F | Partial | Unilateral Cleft Lip and Palate Lt Side | Class III | IC | |
| M | Partial | Unilateral Cleft Lip and Palate Lt Side | Class III | CM | |
| F | Complete | Unilateral Cleft Lip and Palate Lt Side | Class III | CM + IC | |
| F | Partial | Unilateral Cleft Lip and Palate Lt Side | Class III | CM + IC | |
| M | Partial | Unilateral Cleft Lip and Palate Lt Side | Class III | IC | |
| F | Complete | Unilateral Cleft Lip and Palate Lt Side | Class III | CM + IC + Dilaceration | |
| M | Partial | Unilateral Cleft Lip and Palate Rt Side | Class I | CM | |
| M | Partial | Unilateral Cleft Lip and Palate Rt Side | Class III | CM + IC | |
| M | Complete | Unilateral Cleft Lip and Palate Rt Side | Class I | CM | |
| F | Partial | Unilateral Cleft Lip and Alveolus Rt Side | Class III | CM | UCLA = 11.11% |
| F | Complete | Unilateral Cleft Lip Lt Side | Class III | CM | UCL = 30.77% |
| M | Partial | Unilateral Cleft Lip Rt Side | Class III | SN | |
| M | Partial | Unilateral Cleft Lip Rt Side | Class II | CM + IC | |
| F | Complete | Unilateral Cleft Lip Rt Side | Class III | CM |
Gender disparities of all sella turcica morphomometric parameters among all five groups.
| Group | Variables | Gender | Mean | SD | 95% CI | ||
| Lower | Upper | ||||||
| Control | A | Male | 11.164 | 1.690 | −0.685 | 1.369 | 0.501 |
| Female | 10.822 | 1.090 | |||||
| B | Male | 9.669 | 1.466 | −1.105 | 1.123 | 0.987 | |
| Female | 9.659 | 1.544 | |||||
| C | Male | 10.925 | 3.296 | −1.489 | 2.966 | 0.503 | |
| Female | 10.187 | 2.771 | |||||
| D | Male | 8.210 | 1.461 | −0.649 | 1.708 | 0.366 | |
| Female | 7.681 | 1.698 | |||||
| E | Male | 7.779 | 0.911 | −1.049 | 1.329 | 0.812 | |
| Female | 7.639 | 2.007 | |||||
| F | Male | 8.746 | 1.131 | −0.531 | 1.355 | 0.379 | |
| Female | 8.335 | 1.385 | |||||
| G | Male | 77.133 | 22.446 | −9.325 | 23.683 | 0.381 | |
| Female | 69.954 | 22.288 | |||||
| BCLP | A | Male | 8.075 | 0.989 | −0.390 | 1.495 | 0.239 |
| Female | 7.522 | 1.480 | |||||
| B | Male | 7.422 | 1.289 | −0.520 | 1.639 | 0.297 | |
| Female | 6.862 | 1.455 | |||||
| C | Male | 7.663 | 2.258 | −1.330 | 2.366 | 0.570 | |
| Female | 7.145 | 2.398 | |||||
| D | Male | 6.254 | 1.487 | −0.897 | 1.452 | 0.632 | |
| Female | 5.977 | 1.420 | |||||
| E | Male | 6.229 | 1.142 | −0.876 | 1.083 | 0.829 | |
| Female | 6.125 | 1.368 | |||||
| F | Male | 7.210 | 1.308 | −0.928 | 1.365 | 0.699 | |
| Female | 6.991 | 1.650 | |||||
| G | Male | 49.767 | 17.188 | −9.614 | 18.425 | 0.525 | |
| Female | 45.362 | 18.076 | |||||
| UCLP | A | Male | 8.223 | 1.266 | −0.381 | 1.308 | 0.273 |
| Female | 7.759 | 1.324 | |||||
| B | Male | 7.774 | 1.492 | −1.081 | 1.018 | 0.951 | |
| Female | 7.806 | 1.778 | |||||
| C | Male | 9.392 | 2.418 | −1.659 | 1.480 | 0.908 | |
| Female | 9.481 | 2.348 | |||||
| D | Male | 6.903 | 1.227 | −1.034 | 0.513 | 0.499 | |
| Female | 7.164 | 1.089 | |||||
| E | Male | 6.895 | 1.054 | −0.798 | 0.549 | 0.710 | |
| Female | 7.019 | 0.977 | |||||
| F | Male | 7.278 | 1.158 | −0.872 | 0.582 | 0.689 | |
| Female | 7.423 | 1.013 | |||||
| G | Male | 57.560 | 12.685 | −6.058 | 10.327 | 0.601 | |
| Female | 55.425 | 12.139 | |||||
| UCL | A | Male | 8.873 | 1.495 | −0.940 | 2.356 | 0.365 |
| Female | 8.165 | 1.141 | |||||
| B | Male | 8.034 | 1.636 | −1.968 | 2.016 | 0.979 | |
| Female | 8.010 | 1.616 | |||||
| C | Male | 9.739 | 2.744 | −3.412 | 2.480 | 0.734 | |
| Female | 10.205 | 1.923 | |||||
| D | Male | 7.199 | 1.377 | −2.404 | 0.968 | 0.369 | |
| Female | 7.917 | 1.378 | |||||
| E | Male | 7.543 | 0.845 | −1.474 | 1.400 | 0.956 | |
| Female | 7.580 | 1.474 | |||||
| F | Male | 7.711 | 1.692 | −2.626 | 1.652 | 0.626 | |
| Female | 8.198 | 1.810 | |||||
| G | Male | 62.428 | 21.557 | −29.800 | 19.872 | 0.669 | |
| Female | 67.392 | 18.638 | |||||
| UCLA | A | Male | 8.303 | 1.414 | −2.153 | 1.033 | 0.433 |
| Female | 8.863 | 0.686 | |||||
| B | Male | 8.120 | 1.026 | −3.044 | 2.150 | 0.696 | |
| Female | 8.567 | 1.719 | |||||
| C | Male | 10.167 | 0.257 | −3.081 | 4.514 | 0.669 | |
| Female | 9.450 | 2.683 | |||||
| D | Male | 6.823 | 0.770 | −2.662 | 2.129 | 0.800 | |
| Female | 7.090 | 1.624 | |||||
| E | Male | 6.923 | 1.822 | −3.178 | 3.048 | 0.962 | |
| Female | 6.988 | 1.878 | |||||
| F | Male | 7.040 | 1.574 | −3.876 | 2.599 | 0.655 | |
| Female | 7.678 | 2.064 | |||||
| G | Male | 54.233 | 10.970 | −39.066 | 31.380 | 0.804 | |
| Female | 58.076 | 23.940 | |||||
Descriptive results of all sella turcica morphomometric parameters among all five groups.
| TS-PClin | SA-SP | TS-DS | TS-SF | PClin-SF | SM-SF | TS-SA-SF-SP-PClin | ||||||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
| Control | 10.976 | 1.379 | 9.664 | 1.484 | 10.520 | 2.991 | 7.920 | 1.592 | 7.702 | 1.585 | 8.521 | 1.273 | 73.196 | 22.281 |
| BCLP | 7.884 | 1.185 | 7.229 | 1.350 | 7.484 | 2.278 | 6.159 | 1.445 | 6.193 | 1.201 | 7.134 | 1.409 | 48.248 | 17.306 |
| UCLP | 8.053 | 1.291 | 7.786 | 1.580 | 9.424 | 2.363 | 6.999 | 1.172 | 6.940 | 1.016 | 7.331 | 1.096 | 56.779 | 12.378 |
| UCL | 8.546 | 1.340 | 8.023 | 1.557 | 9.954 | 2.316 | 7.530 | 1.370 | 7.560 | 1.124 | 7.936 | 1.691 | 64.720 | 19.589 |
| UCLA | 8.677 | 0.934 | 8.418 | 1.470 | 9.689 | 2.155 | 7.001 | 1.347 | 6.967 | 1.742 | 7.466 | 1.839 | 56.795 | 19.799 |
Multiple comparison of all sella turcica morphomometric parameters among all five groups.
| Variables | Multiple comparison | MD | SE | 95% CI | ||||
| Lower bound | Upper bound | |||||||
| TS-PClin | Control | vs | BCLP | 3.09199* | 0.329 | 2.150 | 4.034 | 0.000 |
| UCLP | 2.92271* | 0.303 | 2.055 | 3.790 | 0.000 | |||
| UCL | 2.42998* | 0.421 | 1.226 | 3.634 | 0.000 | |||
| UCLA | 2.29946* | 0.482 | 0.919 | 3.680 | 0.000 | |||
| BCLP | vs | UCLP | −0.16928 | 0.309 | −1.054 | 0.715 | 1.000 | |
| UCL | −0.66202 | 0.425 | −1.879 | 0.555 | 1.000 | |||
| UCLA | −0.79253 | 0.486 | −2.183 | 0.598 | 1.000 | |||
| UCLP | vs | UCL | −0.49274 | 0.406 | −1.653 | 0.667 | 1.000 | |
| UCLA | −0.62325 | 0.469 | −1.965 | 0.718 | 1.000 | |||
| UCL | vs | UCLA | −0.13051 | 0.552 | −1.711 | 1.450 | 1.000 | |
| SA-SP | Control | vs | BCLP | 2.43493* | 0.386 | 1.331 | 3.539 | 0.000 |
| UCLP | 1.87769* | 0.356 | 0.860 | 2.895 | 0.000 | |||
| UCL | 1.64047* | 0.494 | 0.228 | 3.053 | 0.012 | |||
| UCLA | 1.24577 | 0.566 | −0.373 | 2.864 | 0.296 | |||
| BCLP | vs | UCLP | −0.55723 | 0.363 | −1.594 | 0.480 | 1.000 | |
| UCL | −0.79446 | 0.499 | −2.221 | 0.632 | 1.000 | |||
| UCLA | −1.18916 | 0.570 | −2.820 | 0.442 | 0.391 | |||
| UCLP | vs | UCL | −0.23722 | 0.476 | −1.598 | 1.123 | 1.000 | |
| UCLA | −0.63192 | 0.550 | −2.205 | 0.941 | 1.000 | |||
| UCL | vs | UCLA | −0.3947 | 0.648 | −2.248 | 1.459 | 1.000 | |
| TS-DS | Control | vs | BCLP | 3.03586* | 0.646 | 1.187 | 4.885 | 0.000 |
| UCLP | 1.09561 | 0.595 | −0.608 | 2.799 | 0.683 | |||
| UCL | 0.56615 | 0.827 | −1.799 | 2.931 | 1.000 | |||
| UCLA | 0.83111 | 0.947 | −1.879 | 3.541 | 1.000 | |||
| BCLP | vs | UCLP | −1.94025* | 0.607 | −3.677 | −0.204 | 0.018 | |
| UCL | −2.46971* | 0.835 | −4.858 | −0.081 | 0.037 | |||
| UCLA | −2.20475 | 0.955 | −4.936 | 0.526 | 0.226 | |||
| UCLP | vs | UCL | −0.52946 | 0.796 | −2.807 | 1.749 | 1.000 | |
| UCLA | −0.2645 | 0.921 | −2.899 | 2.370 | 1.000 | |||
| UCL | vs | UCLA | 0.26496 | 1.085 | −2.838 | 3.368 | 1.000 | |
| TS-SF | Control | vs | BCLP | 1.76106* | 0.358 | 0.737 | 2.785 | 0.000 |
| UCLP | 0.92114 | 0.330 | −0.022 | 1.864 | 0.061 | |||
| UCL | 0.38968 | 0.458 | −0.920 | 1.699 | 1.000 | |||
| UCLA | 0.91857 | 0.525 | −0.582 | 2.419 | 0.825 | |||
| BCLP | vs | UCLP | −0.83992 | 0.336 | −1.801 | 0.122 | 0.138 | |
| UCL | −1.37138* | 0.462 | −2.694 | −0.049 | 0.037 | |||
| UCLA | −0.84249 | 0.529 | −2.355 | 0.670 | 1.000 | |||
| UCLP | vs | UCL | −0.53146 | 0.441 | −1.793 | 0.730 | 1.000 | |
| UCLA | −0.00257 | 0.510 | −1.461 | 1.456 | 1.000 | |||
| UCL | vs | UCLA | 0.52889 | 0.601 | −1.190 | 2.247 | 1.000 | |
| PClin-SF | Control | vs | BCLP | 1.50883* | 0.333 | 0.555 | 2.463 | 0.000 |
| UCLP | 0.76169 | 0.307 | −0.117 | 1.640 | 0.146 | |||
| UCL | 0.14194 | 0.426 | −1.078 | 1.362 | 1.000 | |||
| UCLA | 0.73527 | 0.489 | −0.663 | 2.133 | 1.000 | |||
| BCLP | vs | UCLP | −0.74714 | 0.313 | −1.643 | 0.149 | 0.186 | |
| UCL | −1.36690* | 0.431 | −2.599 | −0.135 | 0.019 | |||
| UCLA | −0.77356 | 0.492 | −2.182 | 0.635 | 1.000 | |||
| UCLP | vs | UCL | −0.61976 | 0.411 | −1.795 | 0.555 | 1.000 | |
| UCLA | −0.02642 | 0.475 | −1.385 | 1.333 | 1.000 | |||
| UCL | vs | UCLA | 0.59333 | 0.560 | −1.008 | 2.194 | 1.000 | |
| SM-SF | Control | vs | BCLP | 1.38651* | 0.348 | 0.392 | 2.381 | 0.001 |
| UCLP | 1.18991* | 0.320 | 0.274 | 2.106 | 0.003 | |||
| UCL | 0.58449 | 0.445 | −0.688 | 1.857 | 1.000 | |||
| UCLA | 1.05509 | 0.510 | −0.403 | 2.513 | 0.406 | |||
| BCLP | vs | UCLP | −0.19659 | 0.327 | −1.131 | 0.738 | 1.000 | |
| UCL | −0.80202 | 0.449 | −2.087 | 0.483 | 0.767 | |||
| UCLA | −0.33142 | 0.513 | −1.800 | 1.138 | 1.000 | |||
| UCLP | vs | UCL | −0.60542 | 0.428 | −1.831 | 0.620 | 1.000 | |
| UCLA | −0.13482 | 0.495 | −1.552 | 1.282 | 1.000 | |||
| UCL | vs | UCLA | 0.4706 | 0.584 | −1.199 | 2.140 | 1.000 | |
| TS-SA-SF-SP-PClin | Control | vs | BCLP | 24.94809* | 4.584 | 11.835 | 38.061 | 0.000 |
| UCLP | 16.41760* | 4.223 | 4.336 | 28.499 | 0.002 | |||
| UCL | 8.4768 | 5.863 | −8.295 | 25.249 | 1.000 | |||
| UCLA | 16.40092 | 6.718 | −2.819 | 35.621 | 0.161 | |||
| BCLP | UCLP | −8.53049 | 4.305 | −20.847 | 3.786 | 0.499 | ||
| UCL | −16.4713 | 5.922 | −33.414 | 0.471 | 0.063 | |||
| UCLA | −8.54716 | 6.770 | −27.915 | 10.821 | 1.000 | |||
| UCLP | UCL | −7.9408 | 5.648 | −24.097 | 8.216 | 1.000 | ||
| UCLA | −0.01667 | 6.531 | −18.702 | 18.668 | 1.000 | |||
| UCL | UCLA | 7.92413 | 7.694 | −14.087 | 29.935 | 1.000 | ||